Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements (English, HTML)
Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements: English HTML file. From Health Canada, updated Jul 2022. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2022-07-28
COVID-19 drugs must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with the international requirements outlined in the International Council for Harmonization Q7A guideline and with applicable Health Canada's guidance.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file